Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcutis Biotherapeutics (ARQT) Tax Provisions (2023 - 2025)

Historic Tax Provisions for Arcutis Biotherapeutics (ARQT) over the last 3 years, with Q3 2025 value amounting to $80000.0.

  • Arcutis Biotherapeutics' Tax Provisions changed N/A to $80000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 19340.97%. This contributed to the annual value of $647000.0 for FY2024, which is 7921.62% down from last year.
  • Latest data reveals that Arcutis Biotherapeutics reported Tax Provisions of $80000.0 as of Q3 2025.
  • In the past 5 years, Arcutis Biotherapeutics' Tax Provisions ranged from a high of $3.0 million in Q3 2023 and a low of $25000.0 during Q4 2023
  • For the 3-year period, Arcutis Biotherapeutics' Tax Provisions averaged around $628000.0, with its median value being $323000.0 (2024).
  • As far as peak fluctuations go, Arcutis Biotherapeutics' Tax Provisions surged by 119200.0% in 2024, and later tumbled by 1388.89% in 2025.
  • Quarter analysis of 3 years shows Arcutis Biotherapeutics' Tax Provisions stood at $25000.0 in 2023, then surged by 1192.0% to $323000.0 in 2024, then tumbled by 75.23% to $80000.0 in 2025.
  • Its Tax Provisions was $80000.0 in Q3 2025, compared to $342000.0 in Q2 2025 and $279000.0 in Q1 2025.